FDA — authorised 9 August 2024
- Application: BLA761382
- Marketing authorisation holder: SANDOZ INC
- Local brand name: ENZEEVU
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 ENZEEVU in United States
FDA authorised ENZEEVU on 9 August 2024
Marketing authorisations
FDA
- Status: approved
ENZEEVU in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is ENZEEVU approved in United States?
Yes. FDA authorised it on 9 August 2024; FDA has authorised it.
Who is the marketing authorisation holder for ENZEEVU in United States?
SANDOZ INC holds the US marketing authorisation.